Gas chromatography (GC) analysis ties prenatal mindfulness to shifts in placental fatty acids.
|Articles|October 1, 2004
- LCGC North America-10-01-2004
- Volume 22
- Issue 10
Practical Tips on Preparing Plasma Samples for Drug Analysis Using SPME
Author(s)Fernando M. Lanças, Maria Eugênia C. Queiroz
This month'ss guest authors review the application of solid-phase SPME to the analysis of drugs in human plasma.
Advertisement
Articles in this issue
about 22 years ago
Gradient Performance Checksabout 22 years ago
Coupling Capillary Isoelectric Focusing with Mass Spectrometryabout 22 years ago
Peaks of Interestabout 22 years ago
October Table of Contentsabout 22 years ago
Short Coursesabout 22 years ago
Calendarabout 22 years ago
Finding a Needle in a HaystackAdvertisement
Related to this article
Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC–qTOF–MS) reveal metabolic shifts in tricuspid regurgitation.
How can advanced separations, inert hardware, orthogonal methods, and AI solve key challenges in reliable GLP-1 peptide analysis workflows?
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
Advertisement
Advertisement
Trending on LCGC International
1
LC–MS/MS Dried Blood Spot Test for Galactosemia
2
GLP-1 Peptide Analysis: Challenges and Solutions
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5